Our Partners
Supported by industry leaders
Biology Meets AI
Integrating biology and machine learning is revolutionizing drug discovery, unlocking new therapeutic possibilities.
The Data Explosion: Exponentially growing biological data is creating unprecedented opportunities for AI-driven insights.
Beyond Traditional Computation: 3D simulations and brute-force screening are being replaced by adaptive, predictive approaches that accelerate discovery.
A New Era in Drug Discovery: AI-powered molecular modeling and dynamic protein structure prediction redefine how we identify and develop treatments.
Our Focus
Small Molecules
The foundation of most modern drugs, offering precision, scalability, and proven therapeutic value.
Undiscovered Protein Structures
Nearly half of all known proteins lack structural data, presenting untapped opportunities for drug discovery.
AI-Driven Discovery
Combining computational biology with machine learning to uncover new interactions and accelerate drug development.
Why Prophet?
Scalability – Screen billions in days:
ProPhet analyzes massive chemical libraries with unmatched speed — reducing discovery from years to days.
Our lightweight models adjust quickly to new targets without costly retraining or delays.
We’re tackling dark, complex proteins that remain elusive to traditional methods — unlocking new therapeutic potential.
Just a protein and ligand sequence — no giant datasets or prep needed for powerful predictions.
We support both pharma partnerships and in-house development to generate near- and long-term value.